POTEREPATIDE
UNII QKT6XK4KHV

Substance Identification & Data

This profile provides standardized clinical and technical data for Poterepatide, uniquely identified by the FDA Unique Ingredient Identifier (UNII) QKT6XK4KHV.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 3058127-20-8 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

QKT6XK4KHV

CAS Registry Number

3058127-20-8

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

POTEREPATIDE

Official standardized name for this substance within the FDA UNII nomenclature system.

INN ID

13857

Sequential identifier assigned via the WHO International Nonproprietary Name program.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Poterepatide. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

POTEREPATIDE

Common Names & Synonyms

L-LYSINAMIDE, L-TYROSYL-2-METHYLALANYL-L-.ALPHA.-GLUTAMYLGLYCYL-L-THREONYL-.ALPHA.-METHYL-L-PHENYLALANYL-L-THREONYL-L-SERYL-L-.ALPHA.-ASPARTYL-L-TYROSYL-2-METHYLALANYL-L-ISOLEUCYL-2-METHYLALANYL-L-LEUCYL-L-.ALPHA.-ASPARTYL-L-LYSYL-L-GLUTAMINYL-L-ALANYL-L-GLUTAMINYL-L-ALANYL-L-.ALPHA.-GLUTAMYL-L-PHENYLALANYL-L-VALYL-N6-(N-(21-CARBOXY-1-OXOHENEICOSYL)-L-.GAMMA.-GLUTAMYL-2-(2-(2-AMINOETHOXY)ETHOXY)ACETYL-2-(2-(2-AMINOETHOXY)ETHOXY)ACETYL-2-(2-(2-AMINOETHOXY)ETHOXY)ACETYL)-L-LYSYL-L-TRYPTOPHYL-L-LEUCYL-L-LEUCYL-L-LYSYLGLYCYLGLYCYL-L-PROLYL-L-SERYL-L-SERYLGLYCYL-L-ALANYL-L-PROLYL-L-PROLYL-L-PROLYL-L-SERYL-

L-TYROSYL-2-METHYLALANYL-L-.ALPHA.-GLUTAMYLGLYCYL-L-THREONYL-.ALPHA.-METHYL-L-PHENYLALANYL-L-THREONYL-L -SERYL-L-.ALPHA.-ASPARTYL-L-TYROSYL-2-METHYLALANYL-L-ISOLEUCYL-2-METHYLALANYL-L-LEUCYL-L-.ALPHA.-ASPARTYL-L-LYSYL-L-GLUTAMINYL-L-ALANYL-L-GLUTAMINYL-L-ALANYL-L-.ALPHA.-GLUTAMYL-L-PHENYLALANYL-L-VALYL-N6-((31S)-31,53-DICARBOXY-10,19,28,33-TETRAOXO-3,6,12,15,21,24-HEXAOXA-9,18,27,32-TETRAAZATRIPENTACONTAN-1-OYL)-L-LYSYL-L-TRYPTOPHYL-L-LEUCYL-L-LEUCYL-L-LYSYLGLYCYLGLYCYL-L-PROLYL-L-SERYL-L-SERYLGLYCYL-L-ALANYL-L-PROLYL-L-PROLYL-L-PROLYL-L-SERYL-L-LYSINAMIDE

POTEREPATIDE [INN]

External Clinical & Regulatory Resources

Previous UNIIQKT1LC4J1P

Next UNIIQKU5EC2X53